Joshua K. Meisner

Biochemistry, Genetics and Molecular Biology · University of Michigan

Established · publishing since 1991

Angiogenesis and VEGF in Cancer Cardiomyopathy and Myosin Studies Thermoregulation and physiological responses Cell Adhesion Molecules Research Coronary Interventions and Diagnostics

Publications

Citations

468

Est. group size

Recurring co-author estimate

Active years

Publishing since 1991

In context

Among 1,668 established Biochemistry, Genetics and Molecular Biology PIs within our index

Citations: 468cohort median 3,422

Publications / year (recent): 4.0cohort median 4.8

Typically publishes in teams of ~8 · 29% small-team papers (≤3 authors) · across 12 venues

Publication cadence

Publications per year over the last 10 years — averaging 4.0/year recently

Collaborators per year

Distinct co-authors at University of Michigan each year — a rough indication of whether the group around this researcher has been growing or contracting. An estimate from co-authorship, not a roster: collaborators are not necessarily lab members, and recent years can be under-counted while indexing catches up.

Recent publications

Preparing for Tomorrow, Today
Journal of the American College of Cardiology · 2026
Impact of MEK Inhibition on Childhood RASopathy-Associated Hypertrophic Cardiomyopathy
JACC Basic to Translational Science · 2024
PO-04-029 NUTRITIONAL VITAMIN SUPPLEMENTATION IS AN ALTERNATIVE ANTIARRHYTHMIC APPROACH TO PREVENT AND TREAT LETHAL TANGO2 DEFICIENCY DISORDER RELATED VENTRICULAR ARRHYTHMIAS DURING INPATIENT ADMISSION
Heart Rhythm · 2024
PO-04-024 A NOVEL OUTPATIENT TREATMENT STRATEGY FOR VENTRICULAR ARRHYTHMIAS IN TANGO2 DEFICIENCY DISORDER: VITAMIN SUPPLEMENTATION IN LIEU OF ICD AND ANTIARRHYTHMICS
Heart Rhythm · 2024
Increased Disease Severity and Compound Sarcomere Variant Burden in Pediatric-Onset Compared to Adult-Onset MYBPC3-Associated Hypertrophic Cardiomyopathy (MYBPC3+ HCM): Insights from the SHaRe Registry
Journal of Cardiac Failure · 2024
Novel Genetic Associations in Anthracycline Cardiomyopathy (ACM) within the Pediatric Population: Scoping Review Protocol
Deep Blue (University of Michigan) · 2024
MAPK and mTOR Inhibition Improves Childhood RASopathy-Associated Hypertrophic Cardiomyopathy
The Thoracic and Cardiovascular Surgeon · 2023
B‐complex vitamins for patients with <scp>TANGO2</scp>‐deficiency disorder
Journal of Inherited Metabolic Disease · 2022
eP027: Screening for co-incident TANGO2 related metabolic encephalopathy and arrhythmia syndrome in 22q11 deletion syndrome
Genetics in Medicine · 2022
AKT/mTOR and MAPK Inhibition Improves Childhood RASopathic Cardiomyopathy
The Thoracic and Cardiovascular Surgeon · 2022
Abdominal Pain, Fatigue, and Headaches in a 9-year-old Boy
Pediatrics in Review · 2022
Abstract 11055: Outcomes and Progression of Rasopathy-Associated Hypertrophic Cardiomyopathy
Circulation · 2022
Congenital heart defects in CHARGE: The molecular role of CHD7 and effects on cardiac phenotype and clinical outcomes
American Journal of Medical Genetics Part C Seminars in Medical Genetics · 2019
Vascular growth responses to chronic arterial occlusion are unaffected by myeloid specific focal adhesion kinase (FAK) deletion
Scientific Reports · 2016

Publishes in

Circulation×3
American Journal of Medical Genetics Part A×2
The Thoracic and Cardiovascular Surgeon×2
Heart Rhythm×2
Journal of Inherited Metabolic Disease×1

Similar researchers

By research-topic overlap

Peter J. Polverini
Biochemistry, Genetics and Molecular Biology · University of Michigan
Kevin Buno
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
Gabriel Gruionu
Biochemistry, Genetics and Molecular Biology · Indiana University
Daphne Lin
Biochemistry, Genetics and Molecular Biology · University of Michigan
Jacques E. Nör
Biochemistry, Genetics and Molecular Biology · University of Michigan

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 25, 2026.

Claim or correct this profile